Junshan Liu

1.6k total citations
57 papers, 1.2k citations indexed

About

Junshan Liu is a scholar working on Molecular Biology, Immunology and Complementary and alternative medicine. According to data from OpenAlex, Junshan Liu has authored 57 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 15 papers in Immunology and 10 papers in Complementary and alternative medicine. Recurrent topics in Junshan Liu's work include Immune Response and Inflammation (12 papers), Natural product bioactivities and synthesis (7 papers) and Pharmacological Effects of Natural Compounds (7 papers). Junshan Liu is often cited by papers focused on Immune Response and Inflammation (12 papers), Natural product bioactivities and synthesis (7 papers) and Pharmacological Effects of Natural Compounds (7 papers). Junshan Liu collaborates with scholars based in China, Rwanda and France. Junshan Liu's co-authors include Linzhong Yu, Zibin Lu, Huihui Cao, Wen‐Cai Ye, Hongling Zhou, Lijuan Deng, Dongmei Zhang, Chun‐Lin Fan, Huayi Yang and Chuying Huo and has published in prestigious journals such as Journal of the American Chemical Society, Carbohydrate Polymers and Molecules.

In The Last Decade

Junshan Liu

56 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junshan Liu China 20 695 168 156 139 136 57 1.2k
Linzhong Yu China 18 559 0.8× 222 1.3× 138 0.9× 178 1.3× 153 1.1× 52 1.1k
Jiajie Guo China 18 763 1.1× 128 0.8× 138 0.9× 134 1.0× 121 0.9× 51 1.4k
Shyr-Yi Lin Taiwan 27 813 1.2× 171 1.0× 143 0.9× 114 0.8× 87 0.6× 60 1.6k
Bei Tong China 24 797 1.1× 191 1.1× 105 0.7× 198 1.4× 104 0.8× 48 1.6k
Hwa Jung Choi South Korea 18 546 0.8× 113 0.7× 138 0.9× 188 1.4× 125 0.9× 29 1.1k
Ji-Yun Lee South Korea 25 754 1.1× 205 1.2× 324 2.1× 138 1.0× 135 1.0× 70 1.6k
Chunliu Mi China 22 689 1.0× 110 0.7× 84 0.5× 74 0.5× 148 1.1× 41 1.1k
Ting Fan China 15 539 0.8× 314 1.9× 115 0.7× 179 1.3× 108 0.8× 28 1.2k
Hsue‐Yin Hsu Taiwan 21 607 0.9× 90 0.5× 215 1.4× 129 0.9× 161 1.2× 39 1.3k
Chia‐Cheng Li Taiwan 26 552 0.8× 94 0.6× 179 1.1× 283 2.0× 169 1.2× 51 1.3k

Countries citing papers authored by Junshan Liu

Since Specialization
Citations

This map shows the geographic impact of Junshan Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junshan Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junshan Liu more than expected).

Fields of papers citing papers by Junshan Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junshan Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junshan Liu. The network helps show where Junshan Liu may publish in the future.

Co-authorship network of co-authors of Junshan Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Junshan Liu. A scholar is included among the top collaborators of Junshan Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junshan Liu. Junshan Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Xuemei, Bing Chen, Peng Guo, et al.. (2025). Daidzin protects against dengue virus infection by targeting viral envelope protein. Industrial Crops and Products. 226. 120658–120658. 1 indexed citations
2.
3.
Yang, Liling, Junshan Liu, Guangli Yang, et al.. (2025). Liang-Ge-San attenuates virus-induced acute lung injury by targeting FXR-mediated ACE2 downregulation to modulate the formation of the cytokine storm. Phytomedicine. 140. 156584–156584. 1 indexed citations
4.
Yang, Liling, Junshan Liu, Guangli Yang, et al.. (2025). PEBL, a component-based Chinese medicine, reduces virus-induced acute lung injury by targeting FXR to decrease ACE2 levels. Journal of Advanced Research. 80. 1099–1119. 1 indexed citations
5.
Lu, Zibin, Bing Chen, Xuemei He, et al.. (2024). Liang–Ge–San protects against viral infection-induced acute lung injury through inhibiting α7nAChR-mediated mitophagy. Phytomedicine. 135. 156231–156231. 4 indexed citations
6.
He, Xuemei, Zibin Lu, Huihui Cao, et al.. (2024). Tanreqing injection inhibits dengue virus encephalitis by suppressing the activation of NLRP3 inflammasome. Chinese Medicine. 19(1). 24–24. 2 indexed citations
7.
Zhou, Chunhong, et al.. (2023). Salvianolic acids from Salvia miltiorrhiza Bunge and their anti-inflammatory effects through the activation of α7nAchR signaling. Journal of Ethnopharmacology. 317. 116743–116743. 16 indexed citations
8.
He, Xuemei, et al.. (2023). Quassinoids from Eurycoma longifolia with antiviral activities by inhibiting dengue virus replication. Phytomedicine. 110. 154650–154650. 7 indexed citations
9.
Lin, Jiapeng, Maohua Huang, Lei Chen, et al.. (2023). Periplocin inhibits hepatocellular carcinoma progression and reduces the recruitment of MDSCs through AKT/NF-κB pathway. Life Sciences. 324. 121715–121715. 11 indexed citations
10.
Zhou, Chunhong, Linzhong Yu, Huihui Cao, et al.. (2023). Ethyl Lithospermate Reduces Lipopolysaccharide-Induced Inflammation through Inhibiting NF-κB and STAT3 Pathways in RAW 264.7 Cells and Zebrafish. Chinese Journal of Integrative Medicine. 29(12). 1111–1120. 3 indexed citations
11.
Chen, Xi, Huihui Cao, Chunyang Tian, et al.. (2023). N-butanol Extract of Glycyrrhizae Radix et Rhizoma Inhibits Dengue Virus through Targeting Envelope Protein. Pharmaceuticals. 16(2). 263–263. 3 indexed citations
12.
Chen, Xi, Jiabin Yang, Huihui Cao, et al.. (2023). Liang-Ge-San inhibits dengue virus serotype 2 infection by reducing caveolin1-induced cytoplasmic heat shock protein 70 translocation into the plasma membrane. Phytomedicine. 119. 154977–154977. 5 indexed citations
13.
Tian, Chunyang, Chun‐Lin Fan, Junjie Xiao, et al.. (2020). Sheng-Mai Yin exerts anti-inflammatory effects on RAW 264.7 cells and zebrafish. Journal of Ethnopharmacology. 267. 113497–113497. 29 indexed citations
14.
Cao, Huihui, et al.. (2020). Inhibition of the STAT3 Signaling Pathway Contributes to the Anti-Melanoma Activities of Shikonin. Frontiers in Pharmacology. 11. 748–748. 32 indexed citations
15.
Lu, Zibin, Huihui Cao, Chunyang Tian, et al.. (2020). Forsythoside A inhibits adhesion and migration of monocytes to type II alveolar epithelial cells in lipopolysaccharide-induced acute lung injury through upregulating miR-124. Toxicology and Applied Pharmacology. 407. 115252–115252. 14 indexed citations
16.
Fan, Chun‐Lin, Chunyang Tian, Zibin Lu, et al.. (2020). Holistic quality evaluation of Qingwen Baidu Decoction and its anti-inflammatory effects. Journal of Ethnopharmacology. 263. 113145–113145. 13 indexed citations
17.
Lu, Zibin, et al.. (2020). Optimal combination of anti-inflammatory components from Chinese medicinal formula Liang-Ge-San. Journal of Ethnopharmacology. 269. 113747–113747. 17 indexed citations
18.
Liu, Junshan, et al.. (2019). Quinolizidine alkaloids from Sophora tonkinensis and their anti-inflammatory activities. Fitoterapia. 139. 104391–104391. 34 indexed citations
19.
Chen, Liping, Minfeng Chen, Jianyang Hu, et al.. (2017). Arenobufagin inhibits prostate cancer epithelial-mesenchymal transition and metastasis by down-regulating β-catenin. Pharmacological Research. 123. 130–142. 59 indexed citations
20.
Li, Man‐Mei, Shuai Wu, Zhong Liu, et al.. (2012). Arenobufagin, a bufadienolide compound from toad venom, inhibits VEGF-mediated angiogenesis through suppression of VEGFR-2 signaling pathway. Biochemical Pharmacology. 83(9). 1251–1260. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Linzhong Yu Breakdown of academic impact, for papers by Jiajie Guo Breakdown of academic impact, for papers by Shyr-Yi Lin Breakdown of academic impact, for papers by Bei Tong Breakdown of academic impact, for papers by Hwa Jung Choi Breakdown of academic impact, for papers by Ji-Yun Lee Breakdown of academic impact, for papers by Chunliu Mi Breakdown of academic impact, for papers by Ting Fan Breakdown of academic impact, for papers by Hsue‐Yin Hsu Breakdown of academic impact, for papers by Chia‐Cheng Li
Rankless by CCL
2026